Article Details

Ovid Therapeutics Inc (NASDAQ:OVID) Receives Average Recommendation of “Hold” from Analysts

Retrieved on: 2019-07-24 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

Ovid Therapeutics Inc (NASDAQ:OVID) Receives Average Recommendation of “Hold” from Analysts. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC grew its stake in shares of Ovid Therapeutics by 445.6% in the first quarter. <b>Acadian Asset Management</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo